CVS Health Stock-Based Compensation 2010-2025 | CVS

CVS Health annual/quarterly stock-based compensation history and growth rate from 2010 to 2025. Stock-based compensation can be defined as the estimated market value of stock options, warrants and other stock-based compensation given to employees and/or vendors
  • CVS Health stock-based compensation for the quarter ending March 31, 2025 was $126M, a 8.03% decline year-over-year.
  • CVS Health stock-based compensation for the twelve months ending March 31, 2025 was $1.339B, a 10.31% decline year-over-year.
  • CVS Health annual stock-based compensation for 2024 was $0.54B, a 8.16% decline from 2023.
  • CVS Health annual stock-based compensation for 2023 was $0.588B, a 31.54% increase from 2022.
  • CVS Health annual stock-based compensation for 2022 was $0.447B, a 7.64% decline from 2021.
CVS Health Annual Stock-Based Compensation
(Millions of US $)
2024 $540
2023 $588
2022 $447
2021 $484
2020 $400
2019 $453
2018 $280
2017 $234
2016 $222
2015 $230
2014 $165
2013 $141
2012 $132
2011 $135
2010 $150
2009 $165
Sector Industry Market Cap Revenue
Medical Medical Services $78.381B $372.809B
CVS Health Corporation is a pharmacy innovation company. Its offerings include pharmacy benefit management services, mail order, retail and specialty pharmacy, disease management programs, and retail clinics. The Company serves employers, insurance companies, unions, government employee groups, managed care organizations and other sponsors of health benefit plans, and individuals under the CVS Caremark Pharmacy Services, Caremark, CVS Caremark, CarePlus CVS/pharmacy, RxAmerica, Accordant, SilverScript, and Novologix names. CVS Health Corporation, formerly known as CVS Caremark Corporation, is headquartered in Woonsocket, Rhode Island.
Stock Name Country Market Cap PE Ratio
Danaher (DHR) United States $136.013B 25.51
Elevance Health (ELV) United States $62.395B 8.39
Cencora (COR) United States $56.765B 19.75
DiDi Global (DIDIY) China $26.874B 28.55
Labcorp Holdings (LH) United States $20.399B 16.55
Natera (NTRA) United States $18.966B 0.00
BioMerieux (BMXMF) France $16.861B 0.00
EUROFINS SCIENT (ERFSF) Luxembourg $13.991B 0.00
CochLear (CHEOY) Australia $13.143B 0.00
Solventum (SOLV) United States $12.678B 13.42
ICON (ICLR) Ireland $11.592B 10.78
Revvity (RVTY) United States $10.993B 18.92
Viatris (VTRS) United States $10.422B 3.58
Avantor (AVTR) United States $9.056B 13.16
Medpace Holdings (MEDP) United States $8.964B 23.81
Sonic Healthcare (SKHHY) Australia $8.852B 0.00
HealthEquity (HQY) United States $8.449B 37.01
Caris Life Sciences,�Inc (CAI) United States $7.680B 0.00
Charles River Laboratories (CRL) United States $7.587B 14.87
Amplifon S.p.A (AMFPF) Italy $5.378B 29.44
Bausch + Lomb (BLCO) Canada $4.918B 28.96
BrightSpring Health Services (BTSG) United States $3.506B 32.17
Sotera Health (SHC) United States $3.139B 17.84
Surgery Partners (SGRY) United States $2.861B 37.20
Concentras Parent (CON) United States $2.507B 14.49
Organon (OGN) United States $2.459B 2.61
Alignment Healthcare (ALHC) United States $2.455B 0.00
GeneDx Holdings (WGS) United States $2.222B 85.57
Progyny (PGNY) United States $1.886B 41.51
PACS (PACS) United States $1.823B 0.00
Premier (PINC) United States $1.725B 13.09
GoodRx Holdings (GDRX) United States $1.672B 33.43
Ardent Health (ARDT) United States $1.589B 6.77
Teladoc Health (TDOC) United States $1.412B 0.00
QDM (QDMI) Hong Kong, SAR China $1.277B 438.00
Establishment Labs Holdings (ESTA) $1.202B 0.00
Pediatrix Medical (MD) United States $1.080B 8.22
Ryman Healthcare (RYHTY) New Zealand $0.970B 0.00
Agilon Health (AGL) United States $0.878B 0.00
AMN Healthcare Services Inc (AMN) United States $0.759B 7.10
CareDx (CDNA) United States $0.663B 10.36
Nutex Health (NUTX) United States $0.632B 9.57
So-Young (SY) China $0.595B 0.00
SBC Medicals (SBC) United States $0.585B 0.00
Embecta (EMBC) United States $0.572B 3.85
InnovAge Holding (INNV) United States $0.531B 0.00
LifeMD (LFMD) United States $0.479B 0.00
Auna S.A (AUNA) Luxembourg $0.470B 10.58
Sonida Senior Living (SNDA) United States $0.466B 0.00
Omada Health (OMDA) $0.453B 0.00
COMPASS Pathways (CMPS) United Kingdom $0.402B 0.00
Enhabit (EHAB) United States $0.342B 28.12
Oncology Institute (TOI) United States $0.312B 0.00
Performant Healthcare (PHLT) United States $0.297B 0.00
Beauty Health (SKIN) United States $0.200B 0.00
Pheton Holdings (PTHL) China $0.146B 0.00
DocGo (DCGO) United States $0.146B 23.83
Sera Prognostics (SERA) United States $0.110B 0.00
Ascend Wellness Holdings (AAWH) United States $0.079B 0.00
KindlyMD (NAKA) United States $0.066B 0.00
NeueHealth (NEUE) United States $0.061B 0.00
IceCure Medical (ICCM) Israel $0.060B 0.00
Biodesix (BDSX) United States $0.047B 0.00
Basel Medical Group (BMGL) Singapore $0.044B 0.00
ModivCare (MODV) United States $0.043B 0.00
NeuroOne Medical Technologies (NMTC) United States $0.043B 0.00
OSR Holdings (OSRH) United States $0.020B 0.00
Intelligent Bio Solutions (INBS) United States $0.015B 0.00
Co-Diagnostics (CODX) United States $0.009B 0.00
BioNexus Gene Lab (BGLC) $0.009B 0.00
SeaStar Medical Holding (ICU) United States $0.008B 0.00
XWELL (XWEL) United States $0.006B 0.00
Aclarion (ACON) United States $0.004B 0.00
ISpecimen (ISPC) United States $0.003B 0.00
NewGenIvf Group (NIVF) Thailand $0.002B 0.00
INVO Fertility (IVF) United States $0.002B 0.00
Cano Health (CANOQ) United States $0.000B 0.00